154 related articles for article (PubMed ID: 34648812)
1. FV-429 enhances the efficacy of paclitaxel in NSCLC by reprogramming HIF-1α-modulated FattyAcid metabolism.
Guo Y; Yang L; Guo W; Wei L; Zhou Y
Chem Biol Interact; 2021 Dec; 350():109702. PubMed ID: 34648812
[TBL] [Abstract][Full Text] [Related]
2. Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429.
Guo Q; Lu L; Liao Y; Wang X; Zhang Y; Liu Y; Huang S; Sun H; Li Z; Zhao L
Cell Death Dis; 2018 Jan; 8(1):e3178. PubMed ID: 29324735
[TBL] [Abstract][Full Text] [Related]
3. Dehydroeffusol inhibits hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer cells through the inactivation of Wnt/β-catenin pathway.
Wei H; Zhang F; Wang J; Zhao M; Hou T; Li L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32426814
[TBL] [Abstract][Full Text] [Related]
4. Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism.
Ni T; He Z; Dai Y; Yao J; Guo Q; Wei L
Cell Death Dis; 2017 Jun; 8(6):e2865. PubMed ID: 28594405
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anticancer effects of ginsenoside CK and gefitinib against gefitinib-resistant NSCLC by regulating the balance of angiogenic factors through HIF-1α/VEGF.
Song X; Wang L; Cai P; Xu Y; Liu Q; Fan D
Toxicol Appl Pharmacol; 2024 May; 486():116938. PubMed ID: 38642809
[TBL] [Abstract][Full Text] [Related]
6. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells
Tu X; Zhang J; Yuan W; Wu X; Xu Z; Qing C
Anticancer Agents Med Chem; 2023; 23(19):2083-2094. PubMed ID: 37587804
[TBL] [Abstract][Full Text] [Related]
8. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
9. Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription.
Liu Y; Wang X; Li W; Xu Y; Zhuo Y; Li M; He Y; Wang X; Guo Q; Zhao L; Qiang L
Oncogene; 2020 Nov; 39(45):6893-6905. PubMed ID: 32978517
[TBL] [Abstract][Full Text] [Related]
10. Cinnamaldehyde induces apoptosis and reverses epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in non-small cell lung cancer.
Wu C; Zhuang Y; Jiang S; Tian F; Teng Y; Chen X; Zheng P; Liu S; Zhou J; Wu J; Wang R; Zou X
Int J Biochem Cell Biol; 2017 Mar; 84():58-74. PubMed ID: 28093328
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C
J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814
[TBL] [Abstract][Full Text] [Related]
12. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
14. Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.
Marostica LL; de Barros ALB; Oliveira J; Salgado BS; Cassali GD; Leite EA; Cardoso VN; Lang KL; Caro MSB; Durán FJ; Schenkel EP; de Oliveira MC; Simões CMO
Toxicol Appl Pharmacol; 2017 Aug; 329():272-281. PubMed ID: 28610991
[TBL] [Abstract][Full Text] [Related]
15. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation.
Chi Y; Luo Q; Song Y; Yang F; Wang Y; Jin M; Zhang D
J Cell Biochem; 2019 Nov; 120(11):19019-19030. PubMed ID: 31241217
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
18. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.
Huang L; Ao Q; Zhang Q; Yang X; Xing H; Li F; Chen G; Zhou J; Wang S; Xu G; Meng L; Lu Y; Ma D
J Cancer Res Clin Oncol; 2010 Mar; 136(3):447-56. PubMed ID: 19760195
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
